News & Resources

  • All
  • Events
  • In the News
  • Press Releases
All
  • All
  • Events
  • In the News
  • Press Releases

Intrommune Therapeutics Appoints Sergi Trilla, MD, MBA to its Scientific and Business Advisory Boards

July 28, 2021 Press Releases
Read More

Intrommune Therapeutics to Present at BIO Digital 2021

June 17, 2021 Press Releases
Read More

Drug Development & Delivery: Oral Mucosal Delivery of Allergenic Proteins for Inducing Tolerance in Food Allergic Individuals

March 30, 2021 In the News
Read More

Daily Mail: Peanut Allergies Could Get The Brush Off In Toothpaste Trial

March 25, 2021 In the News
Read More

Intrommune Therapeutics Names Chief Operating Officer

March 24, 2021 Press Releases
Read More

Intrommune Therapeutics selected as a “Winning Startup” in The Innovate Children’s Health Challenge (ICHC)

March 20, 2021 In the News
Read More

White Paper

Request your copy of our white paper


Videos

Want to learn more about Intrommune and our OMIT technology? Watch the videos below.

Play Video
Play Video
Play Video

The time is now for a desensitization method that is safe, effective and easy to use. This is exactly the solution that Intrommune Therapeutics offers.

Tonya Winders

President, CEO
Allergy & Asthma Network

Learn More
Intrommune toothpaste delivers allergen protein
Toothpaste slurry coats the mouth so more allergen protein can bind with cells on the surface of the oral mucosal epithelium. The opposing charges of the protein and surface cells attracts them to each other to form a strong bond.
Langerhans Cells process and display allergen proteins
Oral Langerhans cells capture allergen protein as it diffuses into the oral mucosa, displaying key identifiers on their surface before travelling to regional lymph nodes.  
Langerhan cells trigger the re-education of the immune system
Once in the regional lymph nodes Langerhans cells activate naive T cells causing them to differentiate into either T regulatory (Treg) cells or T helper type 1 (Th1) cells.
Differentiated T Cells decrease the allergic response
Treg and Th cells travel through lymph vessels and distribute themselves throughout the mucosa of the aerodigestive tract where they decrease the allergic immune response the next time there is exposure to the specific allergen protein. 
Previous
Next